Европска Унија - Дански - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiske midler - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - venlafaxinhydrochlorid - depottabletter - 150 mg

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - venlafaxinhydrochlorid - depottabletter - 225 mg

Европска Унија - Дански - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - cinacalcethydrochlorid - filmovertrukne tabletter - 60 mg

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - cinacalcethydrochlorid - filmovertrukne tabletter - 90 mg

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - solifenacinsuccinat - filmovertrukne tabletter - 5 mg

Европска Унија - Дански - EMA (European Medicines Agency)

mylan pharmaceuticals limited - lopinavir, ritonavir - hiv infektioner - antivirale midler til systemisk anvendelse - lopinavir/ritonavir angives i kombination med andre antiretrovirale lægemidler til behandling af human immundefekt virus (hiv-1) inficeret voksne, unge og børn over 2 år. valget af lopinavir/ritonavir til at behandle proteasehæmmer oplevet hiv-1-inficerede patienter bør være baseret på individuelle viral resistens test og historie behandling af patienter.

Европска Унија - Дански - EMA (European Medicines Agency)

janssen-cilag international n.v. - telaprevir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - incivo, i kombination med peginterferon alfa og ribavirin, er indiceret til behandling af genotype-1 kronisk hepatitis c hos voksne patienter med kompenseret leversygdom (herunder skrumpelever):der er i behandling naive;som tidligere er blevet behandlet med interferon alfa (pegyleret eller non-pegyleret) alene eller i kombination med ribavirin, herunder relapsers, delvis respondenter og respondenter null.

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 20 mg